727 followers
RT @FrontOncology: New research: Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases: Mesothelioma i…
RT @FrontOncology: New research: Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases: Mesothelioma i…
New research: Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases: Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent… https://t.